| 16.22 0.27 (1.69%) | 10-06 16:00 | |||||||||||||
|
|
| Short term |  |
|||
| Mid term |  |
|||
| Targets | 6-month : | 19.43 | 1-year : | 22.7 |
| Resists | First : | 16.63 | Second : | 19.43 |
| Pivot price | 15.93  |
|||
| Supports | First : | 15.74 | Second : | 15.19 |
| MAs | MA(5) : | 15.99 |
MA(20) : | 15.94 |
| MA(100) : | 13.45 |
MA(250) : | 13.3 |
|
| MACD | MACD : | 0.1 |
Signal : | 0.2 |
| %K %D | K(14,3) : | 56.7 |
D(3) : | 54.5 |
| RSI | RSI(14): 58.3 |
|||
| 52-week | High : | 16.63 | Low : | 9.52 |
Price has closed above its short-term moving average. Short-term moving average is currently above mid-term; and above long-term moving average. From the relationship between price and moving averages: This stock is BULLISH in short-term; and BULLISH in mid-long term.[ SHC ] has closed below upper band by 19.9%. Bollinger Bands are 55.6% narrower than normal. The narrow width of the bands suggests low volatility as compared to its normal range. The bands have been in this narrow range for 23 bars. This is a sign that the market may be about to initiate a new trend.
| If tomorrow: | Open lower | Open higher |
| High: | 16.31 - 16.37 | 16.37 - 16.43 |
| Low: | 15.54 - 15.61 | 15.61 - 15.68 |
| Close: | 16.1 - 16.22 | 16.22 - 16.33 |
Sotera Health Company provides sterilization, and lab testing and advisory services in the United States, Canada, Europe, and internationally. The company's sterilization services include gamma and electron beam irradiation, and EO processing; Nelson Labs comprise microbiological and analytical chemistry testing; and advisory services for medical device and biopharmaceutical industries. It serves medical devices; pharmaceuticals; food and agricultural products; and commercial, advanced, and specialty application industries. The company was formerly known as Sotera Health Topco, Inc. and changed its name to Sotera Health Company in October 2020. Sotera Health Company was incorporated in 2017 and is headquartered in Broadview Heights, Ohio.
Thu, 02 Oct 2025
Barclays Raises Price Target for Sotera Health (SHC) to $19.00 | - GuruFocus
Thu, 02 Oct 2025
Sotera Health Reaches Analyst Target Price - Nasdaq
Sun, 14 Sep 2025
What Sotera Health (SHC)'s $307 Million Capital Raise Means for Shareholders - simplywall.st
Thu, 04 Sep 2025
Why Sotera Health Company (SHC) Stock Is Trading Lower Today - Yahoo Finance
Wed, 03 Sep 2025
Sotera Health Announces Secondary Offering of Common Stock - GlobeNewswire
Wed, 27 Aug 2025
Should You Buy Sotera Health Company (SHC) After Golden Cross? - Nasdaq
| Price to Book Value: P/BV, a ratio used to compare book value to its current market price, to gauge whether a stock is valued properly. |
Underperform |
| Price to Earnings: PE, the ratio for valuing a company that measures its current share price relative to its earnings per share (EPS). |
Underperform |
| Discounted cash flow: DCF, a valuation method used to estimate the value of an investment based on its expected future cash flows. |
Underperform |
| Return on Assets: ROA, indicates how profitable a company is in relation to its total assets, how efficiently uses assets to generate a profit. |
Outperform |
| Return on Equity: ROE, a measure of financial performance calculated by dividing net income by equity. a gauge of profitability and efficiency. |
Underperform |
| Debt to Equity: evaluate financial leverage, reflects the ability of equity to cover outstanding debts in the event of a business downturn. |
Underperform |
|
Exchange:
NASDAQ
|
|
|
Sector:
Healthcare
|
|
|
Industry:
Medical - Diagnostics & Research
|
|
| Shares Out | 284 (M) |
| Shares Float | 139 (M) |
| Held by Insiders | 2.4 (%) |
| Held by Institutions | 90.5 (%) |
| Shares Short | 8,780 (K) |
| Shares Short P.Month | 13,750 (K) |
| EPS | 0.09 |
| EPS Est Next Qtrly | 0 |
| EPS Est This Year | 0 |
| EPS Est Next Year | 0 |
| Book Value (p.s.) | 1.79 |
| Profit Margin | 2.1 % |
| Operating Margin | 35.3 % |
| Return on Assets (ttm) | 7.2 % |
| Return on Equity (ttm) | 5.1 % |
| Qtrly Rev. Growth | 6.4 % |
| Gross Profit (p.s.) | 2.19 |
| Sales Per Share | 3.94 |
| EBITDA (p.s.) | 1.84 |
| Qtrly Earnings Growth | -6.5 % |
| Operating Cash Flow | 266 (M) |
| Levered Free Cash Flow | 219 (M) |
| PE Ratio | 180.22 |
| PEG Ratio | 0 |
| Price to Book value | 9.01 |
| Price to Sales | 4.11 |
| Price to Cash Flow | 17.31 |
| Dividend | 0 |
| Forward Dividend | 0 |
| Dividend Yield | 0% |
| Dividend Pay Date | Invalid DateTime. |
| Ex-Dividend Date | Invalid DateTime. |
|
|
|
|
|
|
|
|
|